Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes

Journal of Leukocyte Biology

Volumn 84, Issue 3, 2008, Pages 679-688

  Nonaka, Kenichi ^a   Saio, Masanao ^a   Suwa, Tatsuhiko ^a   Frey, Alan B ^b   Umemura, Naoki ^a   Imai, Hisashi ^a   Ouyang, Guan Feng ^a   Osada, Shinji ^a   Balazs, Margit ^c   Adany, Roza ^c   Kawaguchi, Yoshihiro ^a   Yoshida, Kazuhiro ^a   Takami, Tsuyoshi ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Cancer; Granulocyte macrophage colony stimulating factor; Interleukin 13; Interleukin 2; Tumor necrosis factor

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 2;

ADENOCARCINOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CD4+ T LYMPHOCYTE; CELL ISOLATION; CELL MATURATION; CELL SURFACE; MICROENVIRONMENT; MONONUCLEAR PHAGOCYTE; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPPRESSOR CELL; TH1 CELL; TUMOR ASSOCIATED LEUKOCYTE;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; IMMUNOPHENOTYPING; INTERFERON TYPE II; INTERLEUKIN-13; INTERLEUKIN-2; LYMPHOCYTES, TUMOR-INFILTRATING; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; MYELOID CELLS; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TH1 CELLS;

MURINAE;

EID: 50849102018     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1107729     Document Type: Article

References (33)

1. Bronte, V., Serafini, P., Apolloni, E., Zanovello, P. (2001) Tumor-induced immune dysfunctions caused by myeloid suppressor cells. J. Immunother. 24, 431-446.
2. Gabrilovich, D. I., Bronte, V., Chen, S. H., Colombo, M. P., Ochoa, A., Ostrand-Rosenberg, S., Schreiber, H. (2007) The terminology issue for myeloid-derived suppressor cells. Cancer Res. 67, 425.
3. Young, M. R., Aquino, S., Young, M. E. (1989) Differential induction of hematopoiesis and immune suppressor cells in the bone marrow versus in the spleen by Lewis lung carcinoma variants. J. Leukoc. Biol. 45, 262-273.
4. Young, M. R., Ihm, J., Lozano, Y., Wright, M. A., Prechel, M. M. (1995) Treating tumor-bearing mice with vitamin D3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence. Cancer Immunol. Immunother. 41, 37-45.
5. Young, M. R., Lathers, D. M. (1999) Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers. Int. J. Immunopharmacol. 21, 241-252.
6. Young, M. R., Newby, M., Wepsic, H. T. (1987) Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors. Cancer Res. 47, 100-105.
7. Young, M. R., Young, M. E., Wright, M. A. (1990) Myelopoiesis-associated suppressor-cell activity in mice with Lewis lung carcinoma tumors: interferon-γ plus tumor necrosis factor-α synergistically reduce suppressor cell activity. Int. J. Cancer 46, 245-250.
8. Gallina, G., Dolcetti, L., Serafini, P., De Santo, C., Marigo, I., Colombo, M. P., Basso, G., Brombacher, F., Borrello, I., Zanovello, P., Bicciato, S., Bronte, V. (2006) Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J. Clin. Invest. 116, 2777-2790.
9. Sica, A., Bronte, V. (2007) Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 117, 1155-1166.
10. Frey, A. B. (2006) Myeloid suppressor cells regulate the adaptive immune response to cancer. J. Clin. Invest. 116, 2587-2590.
11. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
12. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., Sica, A. (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549-555.
13. Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., Hill, A. M. (2000) M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164, 6166-6173.
14. Ouyang, G. F., Saio, M., Suwa, T., Imai, H., Nakagawa, J., Nonaka, K., Umemura, N., Kijima, M., Takami, T. (2006) Interleukin-2 augmented activation of tumor associated macrophage plays the main role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro. Int. J. Oncol. 28, 1201-1208.
15. Tamakawa, N., Saio, M., Suwa, T., Ohe, N., Yoshimura, S., Iwama, T., Shinoda, J., Sakai, N., Takami, T. (2004) Interleukin-2 activated microglia engulf tumor infiltrating T cells in the central nervous system. Int. J. Mol. Med. 13, 497-503.
16. Nakagawa, J., Saio, M., Tamakawa, N., Suwa, T., Frey, A. B., Nonaka, K., Umemura, N., Imai, H., Ouyang, G. F., Ohe, N., Yano, H., Yoshimura, S., Iwama, T., Takami, T. (2007) TNF expressed by tumor-associated macrophages, but not microglia, can eliminate glioma. Int. J. Oncol. 30, 803-811.
17. Radoja, S., Saio, M., Schaer, D., Koneru, M., Vukmanovic, S., Frey, A. B. (2001) CD8(+) tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis. J. Immunol. 167, 5042-5051.
18. Saio, M., Radoja, S., Marino, M., Frey, A. B. (2001) Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide. J. Immunol. 167, 5583-5593.
19. de Bruijn, M. F., Slieker, W. A., van der Loo, J. C., Voerman, J. S., van Ewijk, W., Leenen, P. J. (1994) Distinct mouse bone marrow macrophage precursors identified by differential expression of ER-MP12 and ER-MP20 antigens. Eur. J. Immunol. 24, 2279-2284.
20. Banyer, J. L., Hapel, A. J. (1999) Myb-transformed hematopoietic cells as a model for monocyte differentiation into dendritic cells and macrophages. J. Leukoc. Biol. 66, 217-223.
21. Bonecchi, R., Bianchi, G., Bordignon, P. P., D'Ambrosio, D., Lang, R., Borsatti, A., Sozzani, S., Allavena, P., Gray, P. A., Mantovani, A., Sinigaglia, F. (1998) Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187, 129-134.
22. Chiu, B. C., Shang, X. Z., Stolberg, V. R., Komuniecki, E., Chensue, S. W. (2002) Population analysis of CD4+ T cell chemokine receptor transcript expression during in vivo type-1 (mycobacterial) and type-2 (schistosomal) immune responses. J. Leukoc. Biol. 72, 363-372.
23. Bingle, L., Brown, N. J., Lewis, C. E. (2002) The role of tumor-associated macrophages in tumor progression: implications for new anticancer therapies. J. Pathol. 196, 254-265.
24. Umemura, N., Saio, M., Suwa, T., Kitoh, Y., Bai, J., Nonaka, K., Ouyang, G. F., Okada, M., Balazs, M., Adany, R., Shibata, T., Takmai, T. (2008) Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics. J. Leukoc. Biol. 83, 1136-1144.
25. Sica, A., Schioppa, T., Mantovani, A., Allavena, P. (2006) Tumor-associated macrophages are a distinct M2 polarized population promoting tumor progression: potential targets of anti-cancer therapy. Eur. J. Cancer 42, 717-727.
26. Mantovani, A., Allavena, P., Sica, A. (2004) Tumor-associated macrophages as a prototypic type II polarized phagocyte population: role in tumor progression. Eur. J. Cancer 40, 1660-1667.
27. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., Locati, M. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686.
28. Biswas, S. K., Gangi, L., Paul, S., Schioppa, T., Saccani, A., Sironi, M., Bottazzi, B., Doni, A., Vincenzo, B., Pasqualini, F., Vago, L., Nebuloni, M., Mantovani, A., Sica, A. (2006) A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation). Blood 107, 2112-2122.
29. Stout, R. D., Jiang, C., Matta, B., Tietzel, I., Watkins, S. K., Suttles, J. (2005) Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol. 175, 342-349.
30. Stout, R. D., Suttles, J. (2004) Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J. Leukoc. Biol. 76, 509-513.
31. Hamilton, J. A. (1997) CSF-1 and cell cycle control in macrophages. Mol. Reprod. Dev. 46, 19-23.
32. Naito, M., Umeda, S., Takahashi, K., Shultz, L. D. (1997) Macrophage differentiation and granulomatous inflammation in osteopetrotic mice (op/op) defective in the production of CSF-1. Mol. Reprod. Dev. 46, 85-91.
33. Gibbons, R., Ross, F. P., Perkins, S. L., Lacey, D. L., Martin, J., Ebner, R., Teitelbaum, S. L., Kahn, A. J. (1994) Interleukin-4 enhances murine bone marrow macrophage M-CSF receptor expression by a posttranscriptional mechanism. Lymphokine Cytokine Res. 13, 85-92.